Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Product news (4 December 2010)

By News team

Accessing SPCs

The list of changes to summaries of product characteristics is not exhaustive. SPCs for a number of medicines licensed in the UK are available online


Discontinued products

Flixotide Diskhaler

The Flixotide (fluticasone propionate; Allen & Hanburys) Diskhaler and refill range has been discontinued by GlaxoSmithKline. The company expects stocks to be exhausted by March 2011, with some strengths unavailable from late December 2010.

Further information from GSK customer care on 0800 221441.

Flixotide Accuhaler and Evohaler will remain available.

Supply issues

Janssen-Cilag products

Intermittent supply shortages of some Janssen-Cilag products are expected until March 2011.

Affected products are

  • Daktarin (miconazole) cream
  • Imodium (loperamide) syrup
  • Nizoral (ketoconazole) shampoo
  • Sporanox (itraconazole) oral liquid
  • Vermox (mebendazole) suspension

Further information from medical information on 01494 567444.

Citation: The Pharmaceutical Journal URI: 11049318

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.